NRX Pharmaceuticals Inc (NRXP) saw an uptrend of 0.94% in the recent trading with $2.15 being its most recent. The current price level -60.19% lower than the highest price of $5.40 marked by the stock while trading over the past 52-weeks, whereas it is 36.08% higher than the lowest price of $1.58 the company dropped to over past 52-weeks. The latest news story on NRXP appeared in (GlobeNewswire) under the title “NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval”.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 1 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.
NRX Pharmaceuticals Inc Earnings – What Happened With NRXP
Coming around sales and income figures on NRXP Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. NRX Pharmaceuticals Inc (NRXP) last released financial results for the quarter that ended 12/31/2024, posting a surprise factor of -108.11% for net revenue.
NRXP – NRX Pharmaceuticals Inc Stock Earnings Estimates
The perspective of NRX Pharmaceuticals Inc (NASDAQ:NRXP)’s current quarter earnings identifies that analysts are in consensus over the estimate of -0.37 for stock’s EPS in the current quarter. NRX Pharmaceuticals Inc (NRXP) last released financial results for the quarter that ended 12/31/2024, posting a surprise factor of -108.11% for net revenue. Company’s EPS for the last quarter was -0.77.
NRX Pharmaceuticals Inc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 27.68 million. NRXP does have institutional investors; and they hold 23.50% of the stock.
As on 2024-06-30, VANGUARD GROUP INC was the top most holder in NRX Pharmaceuticals Inc (NASDAQ:NRXP) with an ownership of 0.24 million shares of the company or 2.285 of the stake worth $0.59 million. The filing also reveals ADVISORSHARES INVESTMENTS LLC as the second largest holder in the company with a control over 1.0277 of the outstanding shares. Its stake is worth $0.28 million for having 0.11 million shares in hand.
GEODE CAPITAL MANAGEMENT, LLC also came holding a key position in the company during the recent quarter and it now holds 0.6243 of the outstanding shares. With this there are now 31.0 institutions which have possession in NRXP’s shares.
